Home
NICE Guidance
Conditions and diseases
Cancer
Oesophageal cancer
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy
Technology appraisal guidance [TA378]
Published:
27 January 2016
Guidance
Tools and resources
Information for the public
History
Do no do examples
Do no do examples for Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy
Title
Year published
Impact Level
No results could be found